Epidermal growth factor receptor (EGFR) mutations in a series of non-small-cell lung cancer (NSCLC) patients and response rate to EGFR-specifi c tyrosine kinase inhibitors (TKIs)
Date issued
2011Journal title
Clinical & Translational Oncology
Type of content
Artigo